Optimizing a two-drug therapy for H. pylori infection
Part of Digestive system, Infections clinical trials.
This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have tested positive for H. pylori and need treatment, and this is your first time treatment has failed.
- You can understand the study and agree to follow all visits and rules.
- You are willing to use effective birth control during the study (if applicable).
- You have not used certain stomach acid medicines or antibiotics in the past 2 to 4 weeks, depending on the type.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.
This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.
This study tests a simpler two-medicine treatment against a four-medicine approach for people whose first H. pylori treatment failed. It aims to see if the simpler option works just as well in clearing the infection.
This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.
This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.
This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.
Hear when a new Helicobacter Pylori Eradication Rate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.